Response of histiocytoses to imatinib mesylate: fire to ashes.
?
['Administration, Oral', 'Adult', 'Aged', 'Antineoplastic Agents/administration & dosage/*therapeutic use', 'Benzamides', 'Brain Neoplasms/diagnosis/drug therapy', 'Diagnosis, Differential', 'Drug Administration Schedule', 'Erdheim-Chester Disease/*diagnosis/*drug therapy', 'Female', 'Genes, abl/genetics', 'Histiocytosis, Langerhans-Cell/*diagnosis/*drug therapy', 'Humans', 'Imatinib Mesylate', 'Lung Neoplasms/diagnosis/drug therapy', 'Male', 'Middle Aged', 'Mutation', 'Piperazines/administration & dosage/*therapeutic use', 'Positron-Emission Tomography', 'Protein Kinase Inhibitors/administration & dosage/*therapeutic use', 'Protein-Tyrosine Kinases/*antagonists & inhibitors/genetics', 'Proto-Oncogene Proteins c-kit/genetics', 'Pyrimidines/administration & dosage/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Receptor, Platelet-Derived Growth Factor beta/genetics', 'Remission Induction', 'Tomography, X-Ray Computed', 'Treatment Outcome']